As for ovarian cancer, the estimated penetrance by age 70 was 48.3% (95% CI = 38.8% to 57.9%) for BRCA1 mutation carriers and 20.0% (95% CI = 13.3% to 29.0%) for BRCA2 mutation carriers (24). The gene discussed is BRCA2; the disease is ovarian cancer.